Related references
Note: Only part of the references are listed.Proteomic and cell biological profiling of the renal phenotype of the mdx-4cv mouse model of Duchenne muscular dystrophy
Paul Dowling et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2020)
Loss of ACSM3 confers worsened prognosis and immune exclusion to cutaneous melanoma
Zhidong Zhu et al.
JOURNAL OF CANCER (2020)
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Michael-Antony Lisio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Akt in cancer: Mediator and more
Sundaramoorthy Revathidevi et al.
SEMINARS IN CANCER BIOLOGY (2019)
Extracellular Matrix Alterations in Metastatic Processes
Mayra Paolillo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
SPP1 promotes ovarian cancer progression via Integrin beta 1/FAK/AKT signaling pathway
Biao Zeng et al.
ONCOTARGETS AND THERAPY (2018)
VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers
Ruben A. Bartolome et al.
ONCOTARGET (2017)
Ovarian Cancer Prevention, Screening, and Early Detection Report From the 11th Biennial Ovarian Cancer Research Symposium
Jeremy Chien et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression
Ramani Gopal et al.
CELLULAR ONCOLOGY (2017)
A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies
Lin Cheng et al.
JOURNAL OF OVARIAN RESEARCH (2017)
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
Marina Riggio et al.
SCIENTIFIC REPORTS (2017)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer
Ulrich H. Weidle et al.
CANCER GENOMICS & PROTEOMICS (2016)
Inhibition of integrin 1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway
Lei Zhang et al.
MOLECULAR MEDICINE REPORTS (2015)
Activation of Integrin beta 1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines
Zongyuan Yang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Effects of Ganfukang (e,eacurrency signia0•) on expression of connective tissue growth factor and focal adhesion kinase/protein kinase B signal pathway in hepatic fibrosis rats
Zhang Kun et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2014)
Very Long-Chain Acyl-CoA Synthetase 3: Overexpression and Growth Dependence in Lung Cancer
Zhengtong Pei et al.
PLOS ONE (2013)
Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells
Man-Tat Lau et al.
CANCER LETTERS (2012)
Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway
Vicky De Preter et al.
INFLAMMATORY BOWEL DISEASES (2012)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity
Marie E. Monaco et al.
TRANSLATIONAL ONCOLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Share Paper
